Search results
Author(s):
Ankit Agrawal
,
Toshiaki Isogai
,
Shashank Shekhar
,
et al
Added:
12 months ago
Author(s):
Soraya M Samii
,
Javier E Banchs
Added:
3 years ago
Abstract
The concept of using an implantable device to manage arrhythmias and heart failure started over 50 years ago. Since then, we have seen these devices improve patient outcomes from bradyarrhythmias, atrial fibrillation, ventricular arrhythmias, and heart failure. These devices are now standard of care in the management of patients and include pacemakers, implantable cardioverter…
View more
Author(s):
Mandeep Mehra
,
Christian Inchaustegui
Added:
4 months ago
AHA 2023 - Investigator, Dr Mandeep Mehra (Brigham and Women's Hospital, US) is interviewed by Dr Christian Inchaustegui (Oregon Health & Science University, US), CardioNerds Ambassador, on the findings of the ARIES HM3 trial (NCT04069156).ARIES HM3 is a prospective, randomised, double-blinded, placebo-controlled clinical investigation into heart failure (HF) patients treated with the ARIES…
View more
Author(s):
Soraya M Samii
,
Javier E Banchs
Added:
3 years ago
The use of implantable devices to treat arrhythmias started with the implantable pacemaker back in the late 1950s. The risks and costs of implantation limited the indications for the procedure initially. A similar pattern was seen with the initial implantable cardioverter-defibrillators (ICDs) in the early 1980s. In the late 1990s, technology of both these devices focused on the management of…
View more
Author(s):
Michael Joner
Added:
6 years ago
In this video, Dr Michael Joner discusses 'What Is the Most Important Trial to Support the Use of OCT?'.
View more
Transseptal Access After Interatrial Shunt Devices: Try Everything Once and Great Things Twice
Author(s):
Molly Silkowski
,
Nicholas Amoroso
Added:
3 months ago
Article
Left Atrial Appendage Closure Devices for Stroke Prevention in Patients with Non-Valvular AF
Author(s):
Daniel A McBride
,
Timothy M Markman
,
Jackson J Liang
,
et al
Added:
3 years ago
Article
Author(s):
Vincent W Dennis
Added:
3 years ago
About 26% of the adult population worldwide has hypertension. In the US adult population, about 30% have hypercholesterolemia and 50–75%, depending on age range, share both. In addition, hypertension and hypercholesterolemia frequently coexist with diabetes, chronic kidney disease, cigarette smoking, obesity and sedentary lifestyle, all of which are potent risk factors for cardiovascular diseases…
View more
Author(s):
Vincent W Dennis
Added:
3 years ago
About 26% of the adult population worldwide has hypertension. In the US adult population, about 30% have hypercholesterolemia and 50-75%, depending on age range, share both. In addition, hypertension and hypercholesterolemia frequently coexist with diabetes, chronic kidney disease, cigarette smoking, obesity and sedentary lifestyle, all of which are potent risk factors for cardiovascular diseases…
View more